Developed a device for continuous monitoring of blood glucose levels
American Chemical Pharmaceutical Corporation Abbott Laboratories Inc. presented a device for continuous monitoring of blood glucose levels.
Experts say that the system has shown itself to be positive during all laboratory tests. It also affected the decrease in blood sugar levels in people with type 2 diabetes.
A further study involved 363 patients with type 2 diabetes. The average age of the subjects was 63 years.
Participants were encouraged to use a continuous glucose monitoring system developed by Abbott Laboratories Inc.
As a result, doctors recorded a decrease in hemoglobin A1c by almost 1%.
Thus, experts with confidence declare that their development will allow diabetics to stop the constant analyzes of glucose in capillary blood.